Inventor · disambiguated record
Wieslaw Mieczyslaw Kazmierski
Also filed as: KAZMIERSKI WIESLAW · KAZMIERSKI WIESLAW M · KAZMIERSKI WIESLAW MIECZYSLAW
22 granted patents·10 pending applications·45 citations·filing 1997–2022
92Inventor score
Files withGLAXOSMITHKLINE IP DEV LTD12SMITHKLINE BEECHAM CORP7MOLICHEM MEDICINES INC3BIOHAVEN THERAPEUTICS LTD2GLAXOSMITHKLINE LLC2
Top patents by PatentIndex Score
32 records- 0188US10358427B2Modulators of indoleamine 2,3-dioxygenaseGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Jul 23, 2019·11 cites·8 claims
- 0282US8492554B2Chemical compoundsGLAXOSMITHKLINE LLC·Filed 2012·Granted Jul 23, 2013·5 cites·13 claims
- 0376US7645771B2CCR5 antagonists as therapeutic agentsSMITHKLINE BEECHAM CORP·Filed 2003·Granted Jan 12, 2010·16 cites·4 claims
- 0468US7271172B2Pyrrolidine and azetidine compounds as CCR5 antagonistsSMITHKLINE BEECHAM CORP·Filed 2003·Granted Sep 18, 2007·3 cites·12 claims
- 0565US7589204B2Indane compounds as CCR5 antagonistsSMITHKLINE BEECHAM CORP·Filed 2009·Granted Sep 15, 2009·0 cites·1 claims
- 0664US9163023B2Compounds and methods for treating HIVVIIV HEALTHCARE UK LTD·Filed 2013·Granted Oct 20, 2015·1 cites·17 claims
- 0764US7589207B2Cyclohexyl compounds as CCR5 antagonistsSMITHKLINE BEECHAM CORP·Filed 2003·Granted Sep 15, 2009·2 cites·4 claims
- 0863US7022734B2Treatment of septic shockMOLICHEM MEDICINES INC·Filed 2002·Granted Apr 4, 2006·1 cites·6 claims
- 0957US10899754B2Modulators of indoleamine 2,3-dioxygenaseGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Jan 26, 2021·0 cites·5 claims
- 1056US2002091113A1Treatment of septic shockMOLICHEM MEDICINES INC·Filed 2001·Application pending·0 cites
- 1155US7531661B2Indane compounds as CCR5 antagonistsSMITHKLINE BEECHAM CORP·Filed 2003·Granted May 12, 2009·0 cites·1 claims
- 1253US2023330240A1Technologies for preventing or treating infectionsBIOHAVEN THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1352US8729077B2Anti-viral compounds, compositions, and methods of useSCHMITZ FRANK ULRICH·Filed 2009·Granted May 20, 2014·0 cites·4 claims
- 1452US2009053172A1Heterocyclic compounds as ccr5 antagonistsAQUINO CHRISTOPHER JOSEPH·Filed 2008·Application pending·0 cites
- 1551US10906924B2Modulators of indoleamine 2,3-dioxygenaseGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Feb 2, 2021·0 cites·17 claims
- 1650US7569579B2Cyclopropyl compounds as ccr5 antagonistsSMITHKLINE BEECHAM CORP·Filed 2003·Granted Aug 4, 2009·0 cites·4 claims
- 1749US10787442B2Modulators of indoleamine 2,3-dioxygenaseGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Sep 29, 2020·0 cites·2 claims
- 1849US6465511B1Treatment of septic shockMOLICHEM MEDICINES INC·Filed 1997·Granted Oct 15, 2002·6 cites·4 claims
- 1949US2024335555A1Technologies for preventing or treating infectionsBIOHAVEN THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 2046US7452992B2Heterocyclic compounds as CCR5 antagonistsSMITHKLINE BEECHAM CORP·Filed 2003·Granted Nov 18, 2008·0 cites·20 claims
- 2145US10239894B2Inhibitors of indoleamine 2,3-dioxygenaseGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Mar 26, 2019·0 cites·7 claims
- 2244US10927078B2Modulators of indoleamine 2,3-dioxygenaseGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Feb 23, 2021·0 cites·16 claims
- 2344US8889726B2Chemica compoundsBASKARAN SUBRAMANIAN·Filed 2012·Granted Nov 18, 2014·0 cites·17 claims
- 2443US10472336B2Modulators of indoleamine 2,3-dioxygenaseGLAXOSMITHKLINE IP NO 2 LTD·Filed 2016·Granted Nov 12, 2019·0 cites·11 claims
- 2543US2021186960A1Modulators of indoleamine 2,3-dioxygenaseGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Application pending·0 cites
- 2643US2020239420A1Modulators of indoleamine 2,3-dioxygenaseGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Application pending·0 cites
- 2742US10538495B2Modulators of indoleamine 2,3-dioxygenaseGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Jan 21, 2020·0 cites·2 claims
- 2842US2021139467A1Modulators of indoleamine 2,3-dioxygenaseGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Application pending·0 cites
- 2941US2020291008A1Modulators of indoleamine 2,3-dioxygenaseGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Application pending·0 cites
- 3039US2010196321A1CompoundsGLAXOSMITHKLINE LLC·Filed 2010·Application pending·0 cites
- 3138US2021078988A1Modulators of indoleamine 2,3-dioxygenaseGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Application pending·0 cites
- 3227US8592395B2Therapeutic compoundsDUAN MAOSHENG·Filed 2010·Granted Nov 26, 2013·0 cites·10 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →